Evidence map›Paper›PMID 32957635›Full record

ArticleBiomolecules2020

Allosteric Inhibition of Adenylyl Cyclase Type 5 by G-Protein: A Molecular Dynamics Study.

Elisa Frezza, Tina-Méryl Amans, Juliette Martin

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 16 citations in OpenAlex.

  1. Inhibition of adenylyl cyclase by GTPase-deficient GαCell communication and signaling : CCS · 2024
    Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Elisa FrezzaCiTCoM, CNRS, Université de Paris, F-75006 Paris, France.ORCID 0000-0003-0122-7859
Tina-Méryl AmansCNRS, UMR 5086 Molecular Microbiology and Structural Biochemistry, University of Lyon, F-69367 Lyon, France.ORCID 0000-0001-9855-1940
Juliette MartinCNRS, UMR 5086 Molecular Microbiology and Structural Biochemistry, University of Lyon, F-69367 Lyon, France.ORCID 0000-0002-4787-0885
Université Claude Bernard Lyon 1 · FRCentre National de la Recherche Scientifique · FR

Funding

Seventh Framework Programme 720270 (Human Brain Project SGA1)Seventh Framework Programme 785907 (Human BrainProject SGA2)
6 · The paper itself

Abstract

Adenylyl cyclases (ACs) have a crucial role in many signal transduction pathways, in particular in the intricate control of cyclic AMP (cAMP) generation from adenosine triphosphate (ATP). Using homology models developed from existing structural data and docking experiments, we have carried out all-atom, microsecond-scale molecular dynamics simulations on the AC5 isoform of adenylyl cyclase bound to the inhibitory G-protein subunit Gαi in the presence and in the absence of ATP. The results show that Gαi has significant effects on the structure and flexibility of adenylyl cyclase, as observed earlier for the binding of ATP and Gsα. New data on Gαi bound to the C1 domain of AC5 help explain how Gαi inhibits enzyme activity and obtain insight on its regulation. Simulations also suggest a crucial role of ATP in the regulation of the stimulation and inhibition of AC5.

Indexed as

Molecular Dynamics SimulationProtein DomainsAdenosine TriphosphateAdenylyl CyclasesAllosteric RegulationAnimalsGTP-Binding Protein alpha Subunits, Gi-GoKineticsMiceProtein BindingAdenosine TriphosphateAdenylyl Cyclasesadenylyl cyclase type VGTP-Binding Protein alpha Subunits, Gi-Goallosterydockingenzyme activityflexibilityhomology modelsmolecular dynamicsprotein-protein interactions

Identifiers

PMID32957635
PMCPMC7563791
OpenAlexW3086530017

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.